Literature DB >> 20802027

Rest tremor in advanced essential tremor: a post-mortem study of nine cases.

Elan D Louis1, Nana Asabere, Angus Agnew, Carol B Moskowitz, Arlene Lawton, Etty Cortes, Phyllis L Faust, Jean-Paul G Vonsattel.   

Abstract

BACKGROUND: Rest tremor may occur in as many as 30% of essential tremor (ET) patients. It is not clear whether this tremor is a sentinel marker for brainstem Lewy body pathology. Here we report the clinical and post-mortem findings of nine ET cases with upper-extremity rest tremor in the absence of other parkinsonian features.
METHODS: All brains had a complete neuropathological assessment. Tissue sections from the brainstem and basal ganglia were immunostained with α-synuclein antibody.
RESULTS: All cases had longstanding ET (median duration=42 years) with moderate to severe arm tremor. Rest tremor involved both arms in seven (77.8%) cases and one arm in two cases. The rest tremor score was correlated with the total action tremor score (r=0.69, p=0.04). The number of torpedoes was elevated, and Purkinje cells, reduced. Post-mortem changes in the substantia nigra pars compacta (SNc), caudate, putamen and globus pallidum were minimal, and neither Lewy bodies nor Lewy neurites were evident.
CONCLUSIONS: In nine ET brains with upper-extremity rest tremor, neither Lewy body-containing neurons nor Lewy neurites were found on α-synuclein immunostained sections, and other pathological changes in the basal ganglia were minimal. These data support the notion that isolated rest tremor in longstanding ET is not the expression of underlying Lewy body pathology in the SNc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802027     DOI: 10.1136/jnnp.2010.215681

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

1.  Sleep in essential tremor: a comparison with normal controls and Parkinson's disease patients.

Authors:  Marina Gerbin; Amanda S Viner; Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2011-11-30       Impact factor: 4.891

2.  Essential tremor and Parkinson's disease: lack of a link.

Authors:  Charles H Adler; Holly A Shill; Thomas G Beach
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

3.  Purkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains.

Authors:  Rachel Babij; Michelle Lee; Etty Cortés; Jean-Paul G Vonsattel; Phyllis L Faust; Elan D Louis
Journal:  Brain       Date:  2013-09-12       Impact factor: 13.501

4.  Essential tremor is a neurodegenerative disease.

Authors:  Ubaldo Bonuccelli
Journal:  J Neural Transm (Vienna)       Date:  2012-08-23       Impact factor: 3.575

Review 5.  Essential Tremor Within the Broader Context of Other Forms of Cerebellar Degeneration.

Authors:  Elan D Louis; Phyllis L Faust
Journal:  Cerebellum       Date:  2020-12       Impact factor: 3.847

6.  Prevalence and correlates of rest tremor in essential tremor: cross-sectional survey of 831 patients across four distinct cohorts.

Authors:  E D Louis; N Hernandez; M Michalec
Journal:  Eur J Neurol       Date:  2015-03-19       Impact factor: 6.089

7.  Color vision: a study of essential tremor cases versus normal controls.

Authors:  E D Louis; M Gerbin; A S Viner
Journal:  Eur J Neurol       Date:  2012-03-15       Impact factor: 6.089

Review 8.  The evolving definition of essential tremor: What are we dealing with?

Authors:  Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2017-07-08       Impact factor: 4.891

Review 9.  Essential tremor followed by progressive supranuclear palsy: postmortem reports of 11 patients.

Authors:  Elan D Louis; Rachel Babij; Karen Ma; Etty Cortés; Jean-Paul G Vonsattel
Journal:  J Neuropathol Exp Neurol       Date:  2013-01       Impact factor: 3.685

10.  Elevated brain harmane (1-methyl-9H-pyrido[3,4-b]indole) in essential tremor cases vs. controls.

Authors:  Elan D Louis; Pam Factor-Litvak; Xinhua Liu; Jean-Paul G Vonsattel; Monika Galecki; Wendy Jiang; Wei Zheng
Journal:  Neurotoxicology       Date:  2013-08-02       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.